Aust Ctr for Blood Diseases

Research Output 1984 2019

Filter
Meeting Abstract
2018

KLF1 Acts As a Pioneer Transcription Factor to Open Chromatin and Facilitate Recruitment of GATA1

Gillinder, K. R., Magor, G., Bell, C. C., Ilsley, M. D., Huang, S. & Perkins, A. C., 21 Nov 2018, In : Blood. 132, Suppl 1, p. 501-501 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis

Bergin, K., Yuen, F., Wallington-Beddoe, C. T., Kalff, A., Sirdesai, S., Reynolds, J. & Spencer, A., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3265.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Pomalidomide Alone or in Combination with Low Dose Dexamethasone As Maintenance Following Induction with Pomalidomide and Low Dose Dexamethasone in Relapsed and Refractory Myeloma (ALLG MM14)

Kalff, A., Kennedy, N., Reynolds, J., Quach, H., Ho, P. J., Horvath, N., Mollee, P., D'Rozario, J. M., Taylor, K., Estell, J. & Spencer, A., 21 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 1986.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy: Blood 2018 132:3279

Spencer, A., Quach, H., Horvath, N., Kerridge, I. H., Yuen, F., Lee, E. S-H., Morris, E. S., Kalff, A., Bergin, K., Sirdesai, S., Gorniak, M., Mithraprabhu, S., Khong, T. & Reynolds, J., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3279.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

The role of autophagy in multiple myeloma disease progression

Savvidou, I., Chandrasekara, S. D., Khong, T. T. F. & Spencer, A., Jul 2018, In : Cancer Research. 78, 13 Supplement, 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2017

Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients

Mithraprabhu, S., Savvidou, I., Ramachandran, M., Kalff, A., Khong, T. T., Reed, K., Reynolds, J. & Spencer, A., 7 Dec 2017, In : Blood. 130, Suppl 1, 1 p., 1823.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2016

Roar: A Phase Ib Trial of Oral Azacitidine (CC-486) in Combination with Lenalidomide and Dexamethasone (Rd) for Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma Who Have Failed a Prior Lenalidomide-Containing Regimen

Kalff, A., Reed, K., Khong, T. T., Mithraprabhu, S., Ramachandran, M., Reynolds, J., Bergin, K., Thakurta, A., Wang, M., Spencer, A., Guzman, R., Cuoto, S. & Ren, Y., 2 Dec 2016, In : Blood. 128, 22, 1 p., 2121.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TOP2A a New Predictive Marker of Response to Carfilzomib in Multiple Myeloma

Reale, A., Khong, T., Mithraprabhu, S., Reynolds, J., Ramachandran, M., Savvidou, I., Bergin, K., Hocking, J. & Spencer, A., 2 Dec 2016, In : Blood. 128, 22, 1 p., 4461.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2013

Medicine Meets Mathematics: Measuring ADAM10 Activity Directly On a Forming Thrombus

Arthur, J. F., Pinar, I., Facey, A., Fouras, A., Ryan, K., Andrews, R. K., Carberry, J. & Gardiner, E. E. (ed.), 15 Nov 2013, In : Blood. 122, 21, p. 196-196 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review